Centivax is a vaccine platform biotechnology company aiming to treat and eradicate rapidly mutating pathogens. It develops an universal vaccine for all forms of seasonal and pandemic influenza consisting of low doses of computationally-selected, distant evolutionary variants of influenza hemagluttinin (HA) protein epitopes.